CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in number of drug launches
4.1.2. Increasing pharmaceutical and biotechnology industries
4.1.3. Growing R&D investments
4.2. Market Restraints & Challenges
4.2.1. The dearth of skilled professionals
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Rising pharmaceutical outsourcing
CHAPTER 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET– BY TEST TYPE
5.1. Introduction
5.2. Endotoxin Tests
5.3. Sterility Tests
5.4. Adventitious Agent Detection Tests
5.5. Bioburden Tests
5.6. Residual Host Contaminant Detection Tests
5.7. Cell Line Authentication and Characterization Tests
5.8. Other Tests
CHAPTER 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET– BY PRODUCTS
& SERVICES
6.1. Introduction
6.2. Kits & Reagents
6.3. Services
6.4. Instruments
CHAPTER 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET– BY
APPLICATION
7.1. Introduction
7.2. Vaccine & Therapeutics Development
7.3. Blood and Blood-Related Products Testing
7.4. Cellular and Gene Therapy
7.5. Tissue and Tissue-Related Products Testing
7.6. Stem Cell Research
CHAPTER 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET- BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET- COMPANY
PROFILES
9.1. Source Bioscience Company
9.2. The Merck Group
9.3. Lonza Group Ltd.
9.4. SGS S.A.
9.5. Cytovance Biologics, Inc.
9.6. Avance Biosciences Inc.
9.7. The Sartorius group
9.8. Charles River Laboratories International, Inc.
9.9. Pace Analytical Services Inc.
9.10. Toxikon Corporation
9.11. Eurofins Scientific SE
9.12. Thermo Fisher Scientific Inc.
9.13. WuXi AppTec Group
CHAPTER 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET- COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
